TCG Crossover Management »

Disc Medicine shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Disc Medicine (IRON) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Disc Medicine

Tip: Access up to 7 years of quarterly data

All positions including Disc Medicine held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Disc Medicine by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $22M 487k 45.07

More positions owned by TCG Crossover Management

Cg Oncology Comm (CGON)
Dyne Therapeutics Comm (DYN)
Abivax SA Adrs (ABVX)
Silence Therapeutics Adrs (SLN)
Cogent Biosciences Comm (COGT)
Savara Comm (SVRA)
Madrigal Pharmaceuticals Comm (MDGL)
Edgewise Therapeutics Comm (EWTX)
Keros Therapeutics Comm (KROS)
Mineralys Therapeutics Comm (MLYS)
Ocular Therapeutix Comm (OCUL)
Tyra Biosciences Comm (TYRA)
Kura Oncology Comm (KURA)
Structure Therapeutics Adrs (GPCR)
Centessa Pharmaceuticals Comm (CNTA)

View all positions for TCG Crossover Management

Top funds holding Disc Medicine

Paradigm Biocapital Advisors
Atlas Venture Life Science Advisors
Bain Capital Life Sciences Investors
OrbiMed Advisors
Frazier Life Sciences Management
BlackRock
T. Rowe Price Associates
Vanguard Group
Deerfield Management Company
Logos Global Management
Point72 Asset Management
State Street Corporation
Perceptive Advisors
Saturn V Capital Management
TCG Crossover Management

View all funds holding Disc Medicine